Latest Repros Therapeutics Inc (RPRX) Headlines Repros

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Repros Therapeutics Inc (RPRX) Headlines

Repros Therapeutics Inc.(R) Reports Fourth Quarter and Year End 2013 Financial Results
GlobeNewswire - Thu Mar 13, 8:15AM CDT
Repros Therapeutics Inc. (Nasdaq:RPRX) today announced financial results for the fourth quarter and year ended December 31, 2013.

Bullish Two Hundred Day Moving Average Cross - RPRX
MarketNewsVideo.com - Tue Feb 18, 3:38PM CST
In trading on Tuesday, shares of Repros Therapeutics Inc crossed above their 200 day moving average of $19.54, changing hands as high as $19.87 per share. Repros Therapeutics Inc shares are currently trading up about 6% on the day.

Data on Repros' Androxal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 5:26PM CST
Repros Therapeutics recently released additional results from its phase III study, ZA-300, on candidate Androxal.

Repros Therapeutics (RPRX) Jumps: Stock Rises 6.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 8:46AM CST
Repros Therapeutics was a big mover last session, with shares rising over 6%.

Repros Reports Findings From the Six Month Study of Androxal(R) in Men With Secondary Hypogonadism
GlobeNewswire - Mon Feb 10, 8:39AM CST
-- Greater Than 80% of Men Obtained T in the Normal Range

This Week in Biotech: Sunny, With No Chance of Rain
Sean Williams, The Motley Fool - Motley Fool - Sat Feb 08, 1:05PM CST
With the  SPDR S&P Biotech Index  up 57% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and companies...

Repros Shares Soar After FDA Meeting - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 07, 9:27AM CST
Share price of Repros surged 15.8% after its meeting with the FDA on Androxal

Biotech Winners: Pernix, Myriad, Repros, OraSure
David Williamson and Max Macaluso, The Motley Fool - Motley Fool - Thu Feb 06, 7:40PM CST
In this video from Thursday's Market Checkup , Motley Fool health-care analysts David Williamson and Max Macaluso dive into the biggest stories impacting health-care investors on the market today. In this segment, a look at some big winners during...

Nasdaq stocks posting largest percentage increases
AP - Thu Feb 06, 5:02PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:

Why Repros Therapeutics, Inc. Shares Soared
Sean Williams, The Motley Fool - Motley Fool - Thu Feb 06, 2:11PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Repros Therapeutics , a clinical-stage...

Repros Therapeutics rises on Androxal update
AP - Thu Feb 06, 10:35AM CST
NEW YORK (AP) — Shares of Repros Therapeutics jumped Thursday after the company said it doesn't think it will have to run additional safety studies of its testosterone drug Androxal.

Repros Meets With FDA to Discuss Data Requirements for Androxal(R) in the Treatment of Secondary Hypogonadism
GlobeNewswire - Wed Feb 05, 11:22PM CST
-- NDA submission remains anticipated by year end 2014

Analysis of the Southeast Asian Manufacturing Execution Systems Market
PR Newswire - Thu Jan 30, 6:14AM CST
Reportlinker.com announces that a new market research report is available in its catalogue:

Uptrend Call Working As Repros Therapeutics Stock Rises 18.8% (RPRX)
Comtex SmarTrend(R) - Thu Jan 23, 9:49AM CST
SmarTrend identified an Uptrend for Repros Therapeutics (NASDAQ:RPRX) on December 19th, 2013 at $18.48. In approximately 1 month, Repros Therapeutics has returned 18.78% as of today's recent price of $21.95.

Repros Therapeutics Up 17.2% Since SmarTrend Uptrend Call (RPRX)
Comtex SmarTrend(R) - Thu Jan 16, 9:27AM CST
SmarTrend identified an Uptrend for Repros Therapeutics (NASDAQ:RPRX) on December 19th, 2013 at $18.48. In approximately 4 weeks, Repros Therapeutics has returned 17.15% as of today's recent price of $21.65.

Can the Rally in Repros Therapeutics (RPRX) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jan 16, 5:43AM CST
Can the Rally in Repros Therapeutics (RPRX) Shares Continue?

Pre-Market Pulse: Dendreon, Novartis AG, Stryker, and Repros Therapeutics
PR Newswire - Wed Jan 15, 7:00AM CST
Editor Note: For more information about this release, please scroll to bottom.

Repros Continues to Gain on Androxal News - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 13, 4:00PM CST
Repros has initiated two studies on its secondary hypogonadism candidate, Androxal.

Repros Therapeutics Inc. (RPRX) Stock Research Links

RPRX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Monterey Desalination Project: Costs, Challenges & Future

Updated Category News Views 19

Water Woes Dragging on in Monterey? Alright, let's dive into the nitty-gritty of this water supply saga in the Monterey Peninsula. If you're wondering why California American Water is hustling so hard, it's because the taps around here ain't running like they should. This mess has been stretching on for ages, with everyone thirsty for a sustainable answer. The Cost of...

Continue Reading
Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 36

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Effective Youth Hockey Skills: Mastering the Basics

Updated Category News Views 35

Laying Down the Tracks: Essential Foundations in Hockey When it comes to developing youth hockey skills, there's no magic formula or flashy trick that'll make overnight stars out of young players. According to HelloNation's recent piece featuring hockey development expert Dave Maksymiu, it’s all about going back to basics. This seems to be the memo often missed by...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 35

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Beta Bionics Faces Class Action Lawsuit Amid FDA Concerns

Updated Category News Views 233

Beta Bionics in the Legal Crosshairs When a company like Beta Bionics gets hauled into court, you know it's not just smoky mirrors and boardroom politics. The stakes are high right now, with investors lining up for a class-action lawsuit that zeroes in on a nasty bundle of allegations. This isn't just a blip on the radar. It's a seismic wave in the industry. Allegations...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 19

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Horowitz's $150M Boost for Nevada's First Children's Hospital

Updated Category News Views 109

Big Bucks and Bigger Hearts Boost Pediatric Care in Nevada The world isn't exactly short on folks looking to make a buck, but every so often, someone comes along and wants to make a difference instead. Enter Felicia and Ben Horowitz, handing over a staggering $150 million to Intermountain Health. This isn’t your garden-variety gift—it’s aimed at getting Nevada on...

Continue Reading
Denarius Metals Unveils Technical Insight for Toral Project

Updated Category News Views 44

Denarius Metals Shares Tech Report on Toral Project It's a curious moment in the mining world when Denarius Metals decides to drop their latest gem—a technical report on the Toral Project. We're talking about a full-bodied document rooted in the stringent National Instrument 43-101 standards. This isn't some half-baked release; it's a robust assertion of where they...

Continue Reading
CASEKOO's Spooky Collectibles: Postcards Meet Cases

Updated Category News Views 65

Here we go with an unexpected twist in the phone accessory game. CASEKOO decided it's time to mix things up this Halloween with something as peculiar as it is intriguing: limited-edition Spooky Season Commemorative Postcards. A Spooky Strategy to Celebrate Ten Years Get this, folks—CASEKOO's looking to mark a decade in the business with more than just confetti and a...

Continue Reading
Unicoin’s 'RISE IN PINK' Blends Crypto and Charity

Updated Category News Views 24

The New Face of Charitable Giving: Crypto and Cause Turning the spotlight on how blockchain and altruism can mesh, Unicoin's latest campaign isn’t just your average philanthropic endeavor. With 'RISE IN PINK', they're out to change the game, blending digital assets with a deep human cause—breast cancer awareness and support. Technology Meets Human Cause Imagine...

Continue Reading

Top 5 Most Recently Viewed Articles

Growth Opportunities and Strategic Moves of Mount Logan Capital

Updated Category News Views 423

New Era for Mount Logan Capital Inc. and 180 Degree Capital In an exciting move that establishes a robust alternative asset management platform, Mount Logan Capital Inc. has successfully completed its strategic merger with 180 Degree Capital Corp. This combination represents a significant step for both firms as they collaborate to expand their influence in the U.S....

Continue Reading
Pulse Oil Corp. Reports AGM Insights and Board Transition News

Updated Category News Views 72

Pulse Oil Corp. Shares Insights from Latest AGM Vancouver, British Columbia – Pulse Oil Corp. (TSXV: PUL) recently held its annual general meeting and revealed significant outcomes regarding its leadership structure and strategic initiatives. The meeting, which took place with numerous shareholders in attendance, covered vital topics, including the election of directors...

Continue Reading
Sampo plc Expands Share Buyback Initiative This September

Updated Category News Views 169

Sampo plc Expands Share Buyback Initiative in September Sampo plc, a prominent figure in the financial services sector, recently made headlines with its share buyback program, marking a significant step towards enhancing shareholder value. On September 9, 2025, Sampo plc initiated the acquisition of its own A shares. Details of the Share Buyback On this date, the company...

Continue Reading
Discover How Iona University Empowers Student Success

Updated Category News Views 636

Unlocking Opportunities at Iona University At Iona University, students embark on a transformative journey where real-world experiences blend with vital skills for success. The combination of exceptional internships, distinguished faculty, and a vibrant campus community creates a nurturing environment for students to thrive and stand out in today's competitive landscape....

Continue Reading
Exciting Developments and Leadership at Schafer Condon Carter

Updated Category News Views 166

Significant Changes at Schafer Condon Carter New Leadership Team At Schafer Condon Carter (SCC), the excitement and energy are palpable as the agency adapts to recent transformations. The new executive leadership team is steering the agency toward novel heights. Under the visionary leadership of President and CEO Ben Behrman, key figures like Craig Miller, Amy Cesta, and...

Continue Reading